| 1 |
Apostolopoulou A, Fishman JA. The pathogenesis and diagnosis of Pneumocystis jirovecii pneumonia. J Fungi (Basel). 2022; 8(11): 1167.
|
| 2 |
Lu PX, Deng YY, Liu ST, Liu Y, Liu YX, Wang YX J, et al. Correlation between imaging features of Pneumocystis jirovecii pneumonitis (PCP), CD(4) (+) T lymphocyte count, and plasma HIV viral load: a study in 50 consecutive AIDS patients. Quant Imaging Med Surg. 2012; 2(2): 124-9.
|
| 3 |
Ding L, Huang HX, Wang HY, He HY. Adjunctive corticosteroids may be associated with better outcome for non-HIV Pneumocystis pneumonia with respiratory failure: a systemic review and meta-analysis of observational studies. Ann Intensive Care. 2020; 10(1): 34.
doi: 10.1186/s13613-020-00649-9
pmid: 32198645
|
| 4 |
Maschmeyer G, Helweg-Larsen J, Pagano L, Robin C, Cordonnier C, Schellongowski P, et al. ECIL guidelines for treatment of Pneumocystis jirovecii pneumonia in non-HIV-infected haematology patients. J Antimicrob Chemother. 2016; 71(9): 2405-13.
doi: 10.1093/jac/dkw158
pmid: 27550993
|
| 5 |
Mehta V, Nayyar C, Gulati N, Singla N, Rai S, Chandar J. A comprehensive review of Trichosporon spp.: an invasive and emerging fungus. Cureus. 2021; 13(8): e17345.
|
)
